A mutation in the first ligand-binding repeat of the human very-low-density lipoprotein receptor results in high-affinity binding of the single V1 module to human rhinovirus 2

Journal of Virology

Volumn 79, Issue 23, 2005, Pages 14730-14736

  Nizet, Stephane ^a   Wruss, Juergen ^a   Landstetter, Nathalie ^a   Snyers, Luc ^b   Blaas, Dieter ^a,c  

^a Vienna Biocenter   (Austria)

^b Medical University of Vienna   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE; PROTEIN V1; PROTEIN V2; PROTEIN V3; PROTEIN V5; PROTEIN V6; THREONINE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; GENE MUTATION; GENE SEQUENCE; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS 2; LIGAND BINDING; MUTATIONAL ANALYSIS; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE ANALYSIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; WILD TYPE; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BINDING SITES; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, LDL; RECEPTORS, VIRUS; RHINOVIRUS;

HUMAN RHINOVIRUS 2; HUMAN RHINOVIRUS SP.;

EID: 27744440906     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.23.14730-14736.2005     Document Type: Article

References (35)

1. Barbas, C. F., D. R. Burton, J. D. Scott, and G. J. Silverman. 2001. Phage display: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
2. Brabec, M., G. Baravalle, D. Blaas, and R. Fuchs. 2003. Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH. J. Virol. 77:5370-5377.
3. Daniel, T. O., W. J. Schneider, J. L. Goldstein, and M. S. Brown. 1983. Visualization of lipoprotein receptors by ligand blotting. J. Biol. Chem. 258:4606-4611.
4. Esser, V., L. E. Limbird, M. S. Brown, J. L. Goldstein, and D. W. Russell. 1988. Mutational analysis of the ligand binding domain of the low density lipoprotein receptor. J. Biol. Chem. 263:13282-13290.
5. Fass, D., S. Blacklow, P. S. Kim, and J. M. Berger. 1997. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 388:691-693.
6. Fisher, C., D. Abdul-Aziz, and S. C. Blacklow. 2004. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands. Biochemistry 43:1037-1044.
7. Gaus, K., A. Basran, and E. A. Hall. 2001. Assessment of the fifth ligand-binding repeat (LR5) of the LDL receptor as an analytical reagent for LDL binding. Analyst 126:329-336.
8. Gilbert, J. M., P. Bates, H. E. Varmus, and J. M. White. 1994. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J. Virol. 68:5623-5628.
9. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-Pdb-Viewer: an environment for comparative protein modeling. Electrophoresis 18:2714-2723.
10. Herdy, B., L. Snyers, M. Reithmayer, P. Hinterdorfer, and D. Blaas. 2004. Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras. J. Virol. 78:6766-6774.
11. Hewat, E. A., and D. Blaas. 1996. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. EMBO J. 15:1515-1523.
12. Hewat, E. A., E. Neumann, J. F. Conway, R. Moser, B. Ronacher, T. C. Marlovits, and D. Blaas. 2000. The cellular receptor to human rhinovirus 2 binds around the 5-fold axis and not in the canyon: a structural view. EMBO J. 19:6317-6325.
13. Konecsni, T., L. Kremser, L. Snyers, C. Rankl, F. Kilar, E. Kenndler, and D. Blaas. 2004. Twelve receptor molecules attach per viral particle of human rhinovirus serotype 2 via multiple modules. FEBS Lett. 568:99-104.
14. Ledford, R. M., N. R. Patel, T. M. Demenczuk, A. Watanyar, T. Herbertz, M. S. Collett, and D. C. Pevear. 2004. VP1 sequencing of all human rhinovirus serotypes: insights into genus phytogeny and susceptibility to antiviral capsid-binding compounds. J. Virol. 78:3663-3674.
15. Marlovits, T. C., C. Abrahamsberg, and D. Blaas. 1998. Soluble LDL mini-receptors-minimal structure requirements for recognition of minor group human rhinovirus. J. Biol. Chem. 273:33835-33840.
16. Marlovits, T. C., C. Abrahamsberg, and D. Blaas. 1998. Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection. J. Virol. 72:10246-10250.
17. Mischak, H., C. Neubauer, B. Berger, E. Kuechler, and D. Blaas. 1988. Detection of the human rhinovirus minor group receptor on renaturing Western blots. J. Gen. Virol. 69:2653-2656.
18. Mischak, H., C. Neubauer, E. Kuechler, and D. Blaas. 1988. Characteristics of the minor group receptor of human rhinoviruses. Virology 163:19-25.
19. Moestrup, S. K., K. Kaltoft, L. Sottrup-Jensen, and J. Gliemann. 1990. The human alpha 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition. J. Biol. Chem. 265:12623-12628.
20. Moser, R., L. Snyers, J. Wruss, J. Angulo, H. Peters, T. Peters, and D. Blaas. 2005. Neutralization of a common cold virus by concatemers of the third ligand binding module of the VLDL-receptor strongly depends on the number of modules. Virology 338:259-269.
21. Neubauer, C., L. Frasel, E. Kuechler, and D. Blaas. 1987. Mechanism of entry of human rhinovirus 2 into HeLa cells. Virology 158:255-258.
22. Neumann, E., R. Moser, L. Snyers, D. Blaas, and E. A. Hewat. 2003. A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid. J. Virol. 77:8504-8511.
23. Nykjaer, A., and T. E. Willnow. 2002. The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol. 12:273-280.
24. Olson, N. H., P. R. Kolatkar, M. A. Oliveira, R. H. Cheng, J. M. Greve, A. McClelland, T. S. Baker, and M. G. Rossmann. 1993. Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad. Sci. USA 90:507-511.
25. Ronacher, B., T. C. Marlovits, R. Moser, and D. Blaas. 2000. Expression and folding of human very-low-density lipoprotein receptor fragments: neutralization capacity toward human rhinovirus HRV2. Virology 278:541-550.
26. Rudenko, G., L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, and J. Deisenhofer. 2002. Structure of the LDL receptor extracellular domain at endosomal pH. Science 298:2353-2358.
27. Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31:3381-3385.
28. Semler, B. L., and E. Wimmer. 2002. Molecular biology of picornaviruses. ASM Press, Washington, D.C.
29. Smith, G. P., and J. K. Scott. 1993. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:228-257.
30. Smith, T. J., A. G. Mosser, and T. S. Baker. 1995. Structural studies on the mechanisms of antibody-mediated neutralization of human rhinovirus. Semin. Virol. 6:233-242.
31. Uncapher, C. R., C. M. Dewitt, and R. J. Colonno. 1991. The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 180:814-817.
32. Verdaguer, N., I. Fita, M. Reithmayer, R. Moser, and D. Blaas. 2004. X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein. Nat. Struct. Mol. Biol. 11:429-434.
33. Vlasak, M., S. Blomqvist, T. Hovi, E. Hewat, and D. Blaas. 2003. Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination. J. Virol. 77:6923-6930.
34. Vlasak, M., M. Roivainen, M. Reithmayer, I. Goesler, P. Laine, L. Snyers, T. Hovi, and D. Blaas. 2005. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J. Virol. 79:7389-7395.
35. Wang, Q. Y., W. Huang, K. Dolmer, P. G. Gettins, and L. Rong. 2002. Solution structure of the viral receptor domain of Tva and its implications in viral entry. J. Virol. 76:2848-2856.